2-21002409-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000384.3(APOB):​c.13013G>A​(p.Ser4338Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.757 in 1,598,072 control chromosomes in the GnomAD database, including 468,513 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.77 ( 46113 hom., cov: 32)
Exomes 𝑓: 0.76 ( 422400 hom. )

Consequence

APOB
NM_000384.3 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:20O:1

Conservation

PhyloP100: 0.587

Publications

160 publications found
Variant links:
Genes affected
APOB (HGNC:603): (apolipoprotein B) This gene product is the main apolipoprotein of chylomicrons and low density lipoproteins (LDL), and is the ligand for the LDL receptor. It occurs in plasma as two main isoforms, apoB-48 and apoB-100: the former is synthesized exclusively in the gut and the latter in the liver. The intestinal and the hepatic forms of apoB are encoded by a single gene from a single, very long mRNA. The two isoforms share a common N-terminal sequence. The shorter apoB-48 protein is produced after RNA editing of the apoB-100 transcript at residue 2180 (CAA->UAA), resulting in the creation of a stop codon, and early translation termination. Mutations in this gene or its regulatory region cause hypobetalipoproteinemia, normotriglyceridemic hypobetalipoproteinemia, and hypercholesterolemia due to ligand-defective apoB, diseases affecting plasma cholesterol and apoB levels. [provided by RefSeq, Dec 2019]
APOB Gene-Disease associations (from GenCC):
  • hypercholesterolemia, autosomal dominant, type B
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial hypobetalipoproteinemia 1
    Inheritance: AR, SD, AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Genomics England PanelApp
  • homozygous familial hypercholesterolemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=9.706678E-7).
BP6
Variant 2-21002409-C-T is Benign according to our data. Variant chr2-21002409-C-T is described in ClinVar as Benign. ClinVar VariationId is 128418.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.841 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000384.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
NM_000384.3
MANE Select
c.13013G>Ap.Ser4338Asn
missense
Exon 29 of 29NP_000375.3P04114

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
APOB
ENST00000233242.5
TSL:1 MANE Select
c.13013G>Ap.Ser4338Asn
missense
Exon 29 of 29ENSP00000233242.1P04114

Frequencies

GnomAD3 genomes
AF:
0.769
AC:
116943
AN:
152010
Hom.:
46056
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.849
Gnomad AMI
AF:
0.776
Gnomad AMR
AF:
0.772
Gnomad ASJ
AF:
0.811
Gnomad EAS
AF:
0.265
Gnomad SAS
AF:
0.461
Gnomad FIN
AF:
0.738
Gnomad MID
AF:
0.693
Gnomad NFE
AF:
0.783
Gnomad OTH
AF:
0.772
GnomAD2 exomes
AF:
0.705
AC:
170441
AN:
241800
AF XY:
0.698
show subpopulations
Gnomad AFR exome
AF:
0.850
Gnomad AMR exome
AF:
0.740
Gnomad ASJ exome
AF:
0.803
Gnomad EAS exome
AF:
0.273
Gnomad FIN exome
AF:
0.737
Gnomad NFE exome
AF:
0.785
Gnomad OTH exome
AF:
0.729
GnomAD4 exome
AF:
0.756
AC:
1092526
AN:
1445944
Hom.:
422400
Cov.:
33
AF XY:
0.748
AC XY:
537179
AN XY:
718358
show subpopulations
African (AFR)
AF:
0.857
AC:
28015
AN:
32702
American (AMR)
AF:
0.744
AC:
31927
AN:
42934
Ashkenazi Jewish (ASJ)
AF:
0.806
AC:
20670
AN:
25636
East Asian (EAS)
AF:
0.266
AC:
10521
AN:
39530
South Asian (SAS)
AF:
0.494
AC:
41512
AN:
84042
European-Finnish (FIN)
AF:
0.734
AC:
38856
AN:
52942
Middle Eastern (MID)
AF:
0.680
AC:
3873
AN:
5694
European-Non Finnish (NFE)
AF:
0.792
AC:
873118
AN:
1102758
Other (OTH)
AF:
0.738
AC:
44034
AN:
59706
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
13919
27838
41757
55676
69595
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20402
40804
61206
81608
102010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.769
AC:
117060
AN:
152128
Hom.:
46113
Cov.:
32
AF XY:
0.760
AC XY:
56528
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.849
AC:
35254
AN:
41534
American (AMR)
AF:
0.773
AC:
11806
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.811
AC:
2813
AN:
3468
East Asian (EAS)
AF:
0.265
AC:
1367
AN:
5158
South Asian (SAS)
AF:
0.463
AC:
2229
AN:
4816
European-Finnish (FIN)
AF:
0.738
AC:
7796
AN:
10560
Middle Eastern (MID)
AF:
0.694
AC:
204
AN:
294
European-Non Finnish (NFE)
AF:
0.783
AC:
53266
AN:
67998
Other (OTH)
AF:
0.767
AC:
1620
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1286
2573
3859
5146
6432
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
840
1680
2520
3360
4200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.772
Hom.:
178434
Bravo
AF:
0.778
TwinsUK
AF:
0.793
AC:
2940
ALSPAC
AF:
0.796
AC:
3068
ESP6500AA
AF:
0.843
AC:
3708
ESP6500EA
AF:
0.782
AC:
6721
ExAC
AF:
0.703
AC:
85314
Asia WGS
AF:
0.399
AC:
1390
AN:
3474

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
7
not specified (7)
-
-
3
Hypercholesterolemia, familial, 1 (3)
-
-
2
Familial hypercholesterolemia (2)
-
-
2
Familial hypobetalipoproteinemia 1 (2)
-
-
2
Hypercholesterolemia, autosomal dominant, type B (2)
-
-
2
not provided (2)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Hypercholesterolemia, autosomal dominant, type B;C4551990:Familial hypobetalipoproteinemia 1 (1)
-
-
-
Warfarin response (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.81
T
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.13
DANN
Benign
0.15
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.015
N
MetaRNN
Benign
9.7e-7
T
MetaSVM
Benign
-0.97
T
PhyloP100
0.59
PrimateAI
Benign
0.33
T
PROVEAN
Benign
1.2
N
REVEL
Benign
0.055
Sift
Benign
1.0
T
Sift4G
Benign
0.97
T
Vest4
0.017
MPC
0.035
ClinPred
0.0051
T
GERP RS
1.6
gMVP
0.065
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1042034; hg19: chr2-21225281; COSMIC: COSV51928341; COSMIC: COSV51928341; API